|
|
|
|
| New Injectable Bone Material Invented for Use in Stem Cell Delivery
New Injectable Bone Material Invented for Use in Stem Cell Delivery
http://www.prnewswire.com/news-releases/new-injectable-bone-material-invented-for-use-in-stem-cell-delivery-96404034.html
A team of researchers at the University of Nottingham have invented a new class of materials
that can be injected by surgeons as a low-viscosity fluid into the body that, using body heat as
the only trigger, converts into a tough porous material with mechanical properties that mimic
human cancellous bone.
The mechanism of converting from a liquid to solid is novel, and is so gentle that the
injectable bone can carry living stem cells and temperature-sensitive protein drugs into the
body without compromising their viability or functionality.
This new class of materials can be adjusted to suit the mechanical requirements of different
tissues within the body and can deliver multiple cell types and drug types with excellent
control over the final location of these potent regenerative signals within the body.
"Regenerative medicine holds huge promise for patients because it opens opportunities to
heal tissues that would never repair spontaneously," says Kevin Shakesheff, PhD, Professor
of Advanced Drug Delivery and Tissue Engineering, Head of School of Pharmacy, University of
Nottingham, "A powerful concept in regenerative medicine is the use of a porous material
that fills the space within the body and promotes blood vessel formation, stem cell engraftment,
and ultimately the formation of functional tissue."
Kevin Shakesheff will deliver his speech, Injectable bone for stem cell delivery: A material
that spontaneously converts from a liquid to a porous solid via a new mechanism, at 11:00 AM on
Wednesday, July 14, at the 37th Annual Meeting & Exposition of the Controlled Release
Society (CRS), in the Oregon Convention Center, located in Portland, Oregon.
The Controlled Release Society (CRS) is an international society focused on the science and
technologies for delivery of bioactive agents in pharmaceutical, non-pharmaceutical active
ingredients, and in veterinary/animal-health related fields. The CRS Annual Meeting &
Exposition is the internationally recognized conference for scientists and business development
professionals in controlled release and delivery fields.
June, 14 2010 (PRNewswire-USNewswire)
|
|
|
Licenţa de Ministerul Sănătăţii din Ucraina seria AG № 570573 din 10.03.2011
Licenta de Ministerul Sănătăţii din Ucraina seria AB № 511037 din 03.12.2009 ©
Institutul de terapie celulară 2004-2011
|